Arg(34)GLP-1 (7–37)

Arg(34)GLP‑1 (7–37) is a modified glucagon like peptide 1 incretin peptide variant used as a research intermediate or comparator in glucagon like peptide 1 analogue design; the catalogue item denotes the unacylated research peptide.

Arg(34)GLP-1 (7–37) is associated with metabolic peptide research as a modified incretin mainly used as an unacylated research intermediate, comparator or building block in glucagon like peptide 1 analogue design and receptor pharmacology studies.

Arg(34)GLP-1 (7–37): Batch documents are not yet linked on this site. For this modified endogenous incretin peptide expected evidence includes batch identifier and release date; identity by liquid chromatography mass spectrometry/intact mass and sequence confirmation; analytical HPLC/UPLC chromatogram with method and purity limits; peptide content and residual solvent/water declaration; and assay or bioactivity data where relevant. No batch documentation is shown as available until the record for that specific item is linked and reviewed.

Arg(34)GLP-1 (7–37): Storage depends on the documented supplied presentation; as a modified endogenous incretin peptide verify dry/lyophilised versus solution form, counterion and concentration, solvent or buffer choice, pH sensitivity, container closure compatibility and whether the modification alters proteolytic or aggregation stability. No storage instruction is shown as available until the stability record for that specific item is linked and reviewed.